Healthcare technology, specifically healthcare applications (apps) for smartphone devices, is a rapidly growing field with vastly different targets and purposes. With continuous improvements in both tablets and smartphones, the healthcare app market is one that investors and innovators should watch closely in 2019, said data and analytics company GlobalData.

Diagnostic and Interventional Cardiology (DAIC) was named a finalist in the Social Media Presence category for the 2019 Azbee Awards, at both the regional and national levels. Bestowed annually by the American Society of Business Publication Editors (ASBPE), the Azbee Awards recognize the best editorial, online content and design in business-to-business (B2B) media.

National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black box” from ultrasound contrast agent (UCA) labels.

Swiss-based M.A. MedAlliance SA has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for Selution, its sustained limus release (SLR) drug-eluting balloon (DEB) catheter, for the treatment of coronary disease.

UCLA researchers have identified for the first time the origin of an immune cell that plays a critical role in the formation of healthy heart valves. The findings could pave the way for new treatments for heart valve disorders, which can be caused by congenital defects, aging or disease.

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., resigned from his position March 5 after two years on the job, but said he plans to stay on with the agency into April. According to several major news outlets, the primary reason for Gottlieb’s resignation is so that he can spend more time with his family at home in Connecticut; he had reportedly been commuting to Washington, D.C., throughout his tenure.